Personalised adherence support for maintenance treatment of inflammatory bowel disease: a tailored digital intervention to change adherence-related beliefs and barriers
Authors
Chapman, SarahSibelli, Alice
St-Clair Jones, Anja
Forbes, Alastair
Chater, Angel M.
Horne, Robert
Affiliation
UCL School of PharmacyUniversity of Bath
King’s College London
Brighton and Sussex University Hospitals NHS Trust
University College London Hospitals Trust
Norwich Medical School
University of Bedfordshire
Issue Date
2020-05-07
Metadata
Show full item recordAbstract
Background and aims: Interventions to improve adherence to medication may be more effective if tailored to the individual, addressing adherence-related beliefs about treatment and overcoming practical barriers to daily use. We evaluated whether an algorithm tailoring support to address perceptual and practical barriers to adherence reduced barriers and was acceptable to patients with IBD. Methods: Participants with IBD, prescribed azathioprine and/or mesalazine were recruited via patient groups, social media and hospital clinics and allocated to Intervention or Control Groups. The online intervention comprised messages tailored to address beliefs about IBD and maintenance treatment and provide advice on overcoming practical difficulties with taking regular medication. The content was personalised to address specific perceptual and practical barriers identified by a pre-screening tool. Validated questionnaires assessed barriers to adherence and related secondary outcomes at baseline, one and three months of follow-up. Results: 329 participants were allocated to the Intervention (n=153) and Control (n=176) Groups; just under half (46.2%) completed follow-up. At one and three months the Intervention Group had significantly fewer concerns about IBD medication (p≤.01); and, at three months only, fewer doubts about treatment need, fewer reported practical barriers and lower nonadherence (p<.05). Relative to controls at follow-up, the Intervention Group were more satisfied with information about IBD medicines, and viewed pharmaceuticals in general more positively. Questionnaires, interviews and intervention usage indicated the intervention was acceptable. Conclusions: Personalised adherence support using a digital algorithm can help patients overcome perceptual (doubts about treatment necessity and medication concerns) and practical barriers to adherence.Citation
Chapman S., Sibelli A., St-Clair Jones A., Forbes A., Chater A., Horne R. (2020) 'Personalised adherence support for maintenance treatment of inflammatory bowel disease: a tailored digital intervention to change adherence-related beliefs and barriers', Journal of Crohn's and Colitis, 14 (10), pp.1394-1404.Publisher
Oxford University PressJournal
Journal of Crohn's and ColitisPubMed ID
32379303Type
ArticleLanguage
enISSN
1873-9946ae974a485f413a2113503eed53cd6c53
10.1093/ecco-jcc/jjz034
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Green - can archive pre-print and post-print or publisher's version/PDF
Related articles
- Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
- Authors: Campos S, Portela F, Sousa P, Sofia C
- Issue date: 2016 Nov
- Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease.
- Authors: Horne R, Parham R, Driscoll R, Robinson A
- Issue date: 2009 Jun
- Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease.
- Authors: Fu N, Jacobson K, Round A, Evans K, Qian H, Bressler B
- Issue date: 2017 Aug 7
- Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis.
- Authors: Tiao DK, Chan W, Jeganathan J, Chan JT, Perry J, Selinger CP, Leong RW
- Issue date: 2017 Aug
- Pediatric-to-adult Transition and Medication Adherence in Patients with Inflammatory Bowel Disease.
- Authors: Jeganathan J, Lee CH, Rahme A, Tiao DK, Weston C, Dutt S, Magoffin A, Kwan V, Alswaifi A, Katelaris PH, Gaskin KJ, OʼLoughlin EV, Leong RW
- Issue date: 2017 Jul